Image For Activity Cover
New Horizons for Medical Management of Acromegaly
Course Description

Join this patient-focused presentation featuring practical case-based learning designed to improve clinicians' understanding of the available treatment options, and discuss the decision process for selecting treatment appropriate to each patient.  

Topics covered will include: 

  • Landscape: What's New and What's Changed 
  • Expanding View: Understanding Patients' Treatment Burden and Experience 
  • A New Horizon: Treatment Options for Optimal Outcomes 
  • The Journey: How to Proceed, the Decision Process 
  • Question and Answer 
Target Audience
This activity is intended for endocrinologists and endocrine fellows, primary care physicians, physician’s assistants, nurse practitioners and other healthcare professionals.
Learning Objective

Upon completion of this educational activity, learners will be able to: 

  • Examine the main aspects of acromegaly, including scientific advances and expanding knowledge of disease pathogenesis, improvements in disease management, and new medical therapies (available and in development) to improve disease control. 
  • Establish familiarity with current research related to patient and medical provider reporting of symptoms during treatment.  
  • Enhance understanding of available treatment options and the consequent outcomes (i.e., control of GH/IGF-I levels, amelioration of signs/symptoms, improved QoL, ease of administration) associated with use of these different treatment options 
Accreditation Statement

The Endocrine Society is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. Endocrine Society has achieved Accreditation with Commendation.

AMA PRA Category 1 Credit
The Endocrine Society designates each activity in this course for a maximum of 1.00 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. While offering CME credits noted above, this program is not intended to provide extensive training or certification in the field.

Please note that while other accrediting bodies accept AMA PRA Category 1 credit, we can only award and report this credit for MDs/DOs. For those outside of this accreditation, please complete the participation evaluation and use that certificate as proof of attendance to submit to your accrediting body.

Maintenance of Certification (MOC) - if eligible
Successful completion of each CME activity in this course, which includes participation in the evaluation component, enables the participant to earn up to 1.00 points in the American Board of Internal Medicine (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

For questions about content or obtaining CME credit, please contact the Endocrine Society at

Faculty and Disclosures

Shlomo Melmed, MB ChB - Program Chair 
Professor and Dean 
Cedars-Siani Medical Center 
Los Angeles, CA 

Eliza Geer, MD  
Associate Professor 
Memorial Sloan Kettering 
New York, NY 

Lawrence Katznelson, MD 
Stanford University Medical Center 
Palo Alto, CA 

As a provider of continuing medical education (CME) accredited by the Accreditation Council for Continuing Medical Education, the Endocrine Society has a policy of ensuring that the content and quality of this educational activity are balanced, independent, objective, and scientifically rigorous. The scientific content of this activity was developed under the supervision of the Endocrine Society's Special Programs Committee (SPC). The commercial supporter(s) of this activity have no influence over the planning of this CME activity.

The faculty, committee members, and staff who are in position to control the content of this activity are required to disclose to the Endocrine Society and to learners any relevant financial relationship(s) of the individual or spouse/partner that have occurred within the last 12 months with any commercial interest(s) whose products or services are related to the CME content. Financial relationships are defined by remuneration in any amount from the commercial interest(s) in the form of grants; research support; consulting fees; salary; ownership interest (e.g., stocks, stock options, or ownership interest excluding diversified mutual funds); honoraria or other payments for participation in speakers' bureaus, advisory boards, or boards of directors; or other financial benefits. The intent of this disclosure is not to prevent CME planners with relevant financial relationships from planning or delivery of content, but rather to provide learners with information that allows them to make their own judgments of whether these financial relationships may have influenced the educational activity with regard to exposition or conclusion.

The faculty reported the following relevant financial relationship(s) during the content development process for this activity: 

  • Shlomo Melmed, MD: Consultant, Chiasma Inc, Ionis, Crinetics, Ipsen; Research Grant Support, Pfizer
  • Laurence Katznelson, MD: Research Grant Support, Chiasma Inc.; Advisory Board, Pfizer
  • Eliza B. Geer, MD: Research Support, Novartis, Strongbridge, Chiasma, Ionis, Bristo-Myers Squibb; Consultant, Chiasma; Advisory Board, Strongbridge

The following SPC member who planned and reviewed content for this activity reported relevant financial relationships:

  • Katherine Araque, MD: Speaker, Novo Nordisk, Inc;   Advisory Expert, Corcept

The following SPC Committee members reported financial relationships: 

  • Andjela T. Drincic, MD: Advisory Board Member, Corcept 

  • Sergio Fazio, MD, PhD: Consultant, Amarin, Amgen, Akcea, Aegerion, Esperion, Novartis 

  • Angela M. Leung, MD: Speaker, Medical Education Resources, MCE Conferences 

  • Amy Rothberg, MD: Spouse, consultant of Merck 

  • Jenny Blau, MD: Employee, AstraZeneca 

The Endocrine Society has reviewed these relationships to determine which are relevant to the content of this activity and resolved any identified conflicts of interest for these individuals.  

The following SPC members reported no relevant financial relationships: 
Katherine Araque, MD; Beret Ann Casey, MD; Lorena Alarcon-Casas Wright, MD, Neena Natt, MD; Deborah Sellmeyer, MD; Savitha Subramanian, MD; Soleymani Taraneh, MD; Steven Weitzman, MD

Endocrine Society staff associated with the development of content for this activity reported no relevant financial relationships.

The Endocrine Society staff have reviewed all disclosures and resolved or managed all relevant identified conflicts of interest, as applicable

This education activity is supported by an independent medical educational grant from Chiasma, Inc.

Availability: On-Demand
Available Oct 07, 2020 to Dec 31, 2021
Cost : FREE
Credit Offered:
1 AMA PRA Category 1 Credit
1 ABIM-MOC Point
1 Participation Credit
     EndoCareers | Contact Us | Privacy Policy | Terms of Use CONNECT WITH US                
       © 2021 Copyright Endocrine Society. All rights reserved.
2055 L Street NW, Suite 600 | Washington, DC 20036      
 202.971.3636 | 888.363.6274
Powered By